Palavra-chave: LYMPHOMA

CHILDREN PHENOTYPING LYMPHOMA NON-HODGKIN ADOLESCENT RITUXIMAB HEMATOPOIETIC STEM CELL TRANSPLANTATION METHOTREXATE NON-HODGKIN LYMPHOMA DIFFUSE B-CELL KILLER CELLS IMMUNOHISTOCHEMISTRY LYMPHOMATOID GRANULOMATOSIS MAGNETIC RESSONANCE MORPHOLOGY LYMPH NODE HODGKIN DISEASE/DRUG THERAPY TONSILLAR ASYMMETRY LATIN-AMERICAN GROUO OF LYMPHOMAS (GELL) T/NK-CELL TONSILLAR NEOPLASM DNA RECEPTOR CELL PROLIFERATION PROGNOSTIC FACTOR CRANIAL NERVES THERAPEUTIC AGNORS NON-HODGKIN MALIGNANCY TRANSPLANTATION, AUTOLOGOUS UNILATERAL TONSILAR ENLARGMENT ORAL CAVITY TRANSPLANTATION GLUTATHIONE S-TRANSFERASE MU1 IMMUNOPHENOTYPING T-CELL/PATHOLOGY CENTRAL NERVOUS SYSTEM PALATE IMMUNOPHENOTYPE AUTOLOGOUS BRAZILIANS LYMPHADENOPHATY GENE THETA 1 (GSTT1) PROGNOSIS POLYMORPHISMS ANAPLASTIC T-CELL PROJECT DIFUSE LARGE B-CELL LYMPHOMA AGGRESSIVE NON-HODGKIN NON-HODGKIN´S T-CELL/EPIDEMIOLOGY ADMINISTRATION & DOSAGE ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS TONSIL DNA-ANEUPLOIDY NATURAL-KILLER HEMATOLOGIC NEOPLASM HLA KINASE PALATINE TONSILS NCCN-IPI INTRATHECAL TCELL BRAZIL PROJECT PRE RITUXIMAB ERA